Search results
25 cze 2021 · The overall objective of the guideline is to provide up-to-date, evidence-based recommendations for the management of cutaneous lupus erythematosus (CLE) in the presence or absence of systemic lupus erythematosus (SLE) in adults, young people and children.
5 gru 2023 · General approaches to management as well as organ-specific treatment, including lupus nephritis and cutaneous lupus, will be covered. This will be the first guideline in SLE using a whole life course approach from childhood through adolescence and adulthood.
In this Seminar, we focus on SLE in adults. Globally, estimates of SLE prevalence in adults range from 30 to 150 per 100 000, and incidence ranges from 2·2 to 23·1 per 100 000 per year (table 1). In the USA, the incidence of SLE almost tripled in the late 20th century.
1 sty 2023 · Abstract. The majority of patients with systemic lupus erythematosus (SLE) have cutaneous manifestations at some point in their disease course. The skin findings in SLE are classified as SLE-specific or SLE-nonspecific based on histopathologic findings.
19 maj 2021 · Cutaneous lupus can be subdivided into three main categories: acute cutaneous lupus erythematosus, subacute cutaneous lupus erythematosus, and chronic cutaneous lupus erythematosus. Physical exam, laboratory studies, and histopathology enable differentiation of cutaneous lupus subtypes.
1 lip 2021 · Lupus erythematosus (LE) is one of the most common connective tissue diseases present worldwide and affecting all age groups, genders and ethnicities. 1 Cutaneous manifestations are common in LE, and accurate diagnosis and subclassification of the disease is key to the appropriate clinical management of these patients.
1 wrz 2021 · Cutaneous lupus erythematosus (CLE) is an inflammatory, autoimmune disease encompassing a broad spectrum of subtypes including acute, subacute, chronic and intermittent CLE.
